Research advances of parathyroidectomy in patients with secondary hyperparathyroidism

As one of the advanced complications of end-stage renal disease, secondary hyperparathyroidism (SHPT) leads to many clinical syndromes such as bone lesions, vascular and soft tissue calcification, seriously affecting the quality-of-life of patients and increasing their risks of fractures, cardiovasc...

Full description

Saved in:
Bibliographic Details
Main Authors: Liu Zi-kang, Liang Wei, Ding Guo-hua
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Nephrology 2022-06-01
Series:Linchuang shenzangbing zazhi
Subjects:
Online Access:http://www.lcszb.com/thesisDetails#10.3969/j.issn.1671-2390.2022.06.012
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:As one of the advanced complications of end-stage renal disease, secondary hyperparathyroidism (SHPT) leads to many clinical syndromes such as bone lesions, vascular and soft tissue calcification, seriously affecting the quality-of-life of patients and increasing their risks of fractures, cardiovascular events and even death. Currently SHPT is managed by drug therapy and surgery. Parathyroidectomy is indicated for refractory SHPT patients. This review summarizes the latest pathogenetic mechanisms of SHPT, the choices of different treatments and the complications and managements after SHPT. It was intended as a theoretical basis for treating SHPT.
ISSN:1671-2390